share_log

Tempus AI | 8-K: Current report

Tempus AI | 8-K: Current report

Tempus AI | 8-K：重大事件
美股SEC公告 ·  2024/08/20 16:29

Moomoo AI 已提取核心信息

Tempus AI has made a significant investment in Personalis through multiple transactions on August 16, 2024. The company purchased 3.5 million shares of Personalis common stock at $5.07 per share, totaling $17.7 million. Additionally, Tempus exercised previously issued warrants to acquire 9.2 million shares at exercise prices of $1.50 and $2.50 per share, for an aggregate purchase price of $18.4 million.The companies also amended their Commercialization and Reference Laboratory Agreement, extending the termination notice period to 30 months. The amendment includes enhanced obligations for Personalis regarding potential assignments to competitors and commitments to maintain increased laboratory capacity for new patients. Personalis agreed to register the resale of the newly purchased shares within 30 days.
Tempus AI has made a significant investment in Personalis through multiple transactions on August 16, 2024. The company purchased 3.5 million shares of Personalis common stock at $5.07 per share, totaling $17.7 million. Additionally, Tempus exercised previously issued warrants to acquire 9.2 million shares at exercise prices of $1.50 and $2.50 per share, for an aggregate purchase price of $18.4 million.The companies also amended their Commercialization and Reference Laboratory Agreement, extending the termination notice period to 30 months. The amendment includes enhanced obligations for Personalis regarding potential assignments to competitors and commitments to maintain increased laboratory capacity for new patients. Personalis agreed to register the resale of the newly purchased shares within 30 days.
Tempus AI在2024年8月16日通过多笔交易对Personalis进行了重大投资。该公司以每股5.07美元的价格购买了350万股Personalis普通股，交易总额为1770万美元。此外，Tempus行使了之前发行的Warrants，以1.50美元和2.50美元的行使价格收购920万股，合计购买价格为1840万美元。两家公司还修订了他们的商业化和参考实验室协议，将终止通知期延长至30个月。修订包括Personalis在潜在竞争对手分配和承诺提高新患者实验室容量方面的增强义务。Personalis同意在30天内注册新购买股票的转售。
Tempus AI在2024年8月16日通过多笔交易对Personalis进行了重大投资。该公司以每股5.07美元的价格购买了350万股Personalis普通股，交易总额为1770万美元。此外，Tempus行使了之前发行的Warrants，以1.50美元和2.50美元的行使价格收购920万股，合计购买价格为1840万美元。两家公司还修订了他们的商业化和参考实验室协议，将终止通知期延长至30个月。修订包括Personalis在潜在竞争对手分配和承诺提高新患者实验室容量方面的增强义务。Personalis同意在30天内注册新购买股票的转售。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    相关股票 相关股票
    代码 迷你走势 最新价
    Aclarion
    ACON
    -- 0.0683
    Streamline Health Solutions
    STRM
    -- 4.366
    新氧
    SY
    -- 0.950
    GeneDx Holdings
    WGS
    -- 80.625
    OneMedNet
    ONMD
    -- 1.378
    解锁完整榜单
    热门中概股
    追踪最热门的中概股实时资讯。
    热门讨论
    特斯拉财报在即：股价能否继续攀升？
    🎙️讨论： 1. 面对特朗普回归，特斯拉股价能否在2025年继续攀升？ 2. 特斯拉将在1月29日盘后公布财报，你认为会超出市场预期吗？ 展开
    TSLA财报预告：通过猜测开盘价来获取奖励！